California
Los Angeles The Rituximab Study San Francisco The AbATE Trial - hOKT3γ1(Ala-Ala) in newly diagnosed type 1 diabetes patients The Rituximab Study Stanford The Rituximab Study
Los Angeles The Rituximab Study
San Francisco The AbATE Trial - hOKT3γ1(Ala-Ala) in newly diagnosed type 1 diabetes patients The Rituximab Study
Stanford The Rituximab Study
Colorado
Denver The AbATE Trial - hOKT3γ1(Ala-Ala) in newly diagnosed type 1 diabetes patients The Rituximab Study
Florida
Gainesville The Rituximab Study Miami The Rituximab Study
Gainesville The Rituximab Study
Miami The Rituximab Study
Indiana
Indianapolis The Rituximab Study
Minnesota
Minneapolis The Rituximab Study
New York
New York City The AbATE Trial - hOKT3γ1(Ala-Ala) in newly diagnosed type 1 diabetes patients The Rituximab Study
Pennsylvania
Pittsburgh The Rituximab Study
Texas
Dallas The Rituximab Study
Washington
Seattle The AbATE Trial - hOKT3γ1(Ala-Ala) in newly diagnosed type 1 diabetes patients The Rituximab Study
CANADA
Toronto The Rituximab Study